-
-
-
-
-
-
-
Larimar Therapeutics, Inc. (LRMR) Tops Q2 EPS by 7c
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Larimar Therapeutics, Inc. (LRMR) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
-
-
-
-
-
1,199,221 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

